Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Malignant Lymphoma |
Free Subscription
1 Am J Surg Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A
Clinicopathologic Case-series of 26 Patients of an Underrecognized
Immunophenotypic Variant of Lymphomatoid Papulosis.
Am J Surg Pathol. 2024;48:501-510.
PubMed
Abstract available
B-Lymphoblastic Lymphoma of the Small Bowel: An Extremely Rare Occurrence.
Am Surg. 2023;89:1280-1282.
PubMed
Abstract available
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene
Ciloleucel Across Race and Ethnicity.
Blood. 2024 Apr 18:blood.2023023447. doi: 10.1182/blood.2023023447.
PubMed
Abstract available
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates
with molecular genetic features.
Blood. 2024 Apr 15:blood.2023023242. doi: 10.1182/blood.2023023242.
PubMed
Abstract available
Safety and efficacy of a new academic CD19-directed CAR-T cell for
refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in
Brazil.
Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02283.
PubMed
Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study.
Br J Haematol. 2024 Apr 17. doi: 10.1111/bjh.19470.
PubMed
Abstract available
A safety and efficacy study of allogeneic haematopoietic stem cell
transplantation for refractory and relapsed T-cell acute lymphoblastic
leukaemia/lymphoblastic lymphoma patients who achieved complete remission after
autologous CD7 chimeric antigen r
Br J Haematol. 2024 Apr 13. doi: 10.1111/bjh.19445.
PubMed
Abstract available
Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of
anaplastic large cell lymphoma, ALK-negative.
Br J Haematol. 2024 Apr 12. doi: 10.1111/bjh.19442.
PubMed
Abstract available
PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth
and survival of mantle cell lymphoma.
Cancer Lett. 2024;591:216877.
PubMed
Abstract available
CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in
diffuse large B-cell lymphoma.
Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2874.
PubMed
Abstract available
Post-transplant-cyclophosphamide and short-term Everolimus as
graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and
myeloma-Final results of the phase II OCTET-EVER trial.
Eur J Haematol. 2024 Apr 14. doi: 10.1111/ejh.14210.
PubMed
Abstract available
TP3 binding domain mutations are bad news in Burkitt lymphoma.
Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285213.
PubMed
Abstract available
Involved-site radiotherapy is equally effective and less toxic than
Involved-field radiotherapy in patients receiving combined modality treatment for
early-stage unfavorable Hodgkin lymphoma - an analysis of the randomized phase
III HD17 trial of the
Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00514.
PubMed
Abstract available
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous
Transplant for Hodgkin Lymphoma.
J Clin Oncol. 2024 Apr 18:JCO2302547. doi: 10.1200/JCO.23.02547.
PubMed
Abstract available
Management of relapsed/refractory mantle cell lymphoma.
Leuk Lymphoma. 2024 Apr 18:1-11. doi: 10.1080/10428194.2024.2338851.
PubMed
Abstract available
The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within
the veterans health administration (VHA).
Leuk Lymphoma. 2024 Apr 15:1-10. doi: 10.1080/10428194.2024.2338856.
PubMed
Abstract available
Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant
drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
PLoS One. 2024;19:e0299198.
PubMed
Abstract available
Thank you for your interest in scientific medicine.